These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1576 related items for PubMed ID: 3978657

  • 1. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
    Nitta K, Tanaka T, Takeuchi M.
    Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657
    [Abstract] [Full Text] [Related]

  • 2. Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma.
    Murphy KT, Wardak A, Beckett MA, Lopez CA, Mehta N, Kimchi E, Salloum RM, Jaskowiak NT, Posner MC, Ohno T, Kufe DW, Weichselbaum RR, Mauceri HJ.
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):317-21. PubMed ID: 15887016
    [Abstract] [Full Text] [Related]

  • 3. [Enhancement of immune response by an antitumor agent, cyclophosphamide].
    Nitta K, Tanaka T.
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):706-13. PubMed ID: 2938546
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma.
    Teicher BA, Williams JI, Takeuchi H, Ara G, Herbst RS, Buxton D.
    Anticancer Res; 1998 Mar; 18(4A):2567-73. PubMed ID: 9703911
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of antitumor effect of cyclophosphamide by thaliblastine in Lewis lung carcinoma and L1210 leukemia in mice.
    Stoychkov JN, Miloushev AS.
    Biomedicine; 1980 Apr; 33(2):42-4. PubMed ID: 6447522
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
    Borden EC, Sidky YA, Hatcher JF, Bryan GT.
    Cancer Res; 1988 May 01; 48(9):2329-34. PubMed ID: 3356000
    [Abstract] [Full Text] [Related]

  • 9. In vivo antitumor activity of multiple injections of recombinant interleukin 2, alone and in combination with three different types of recombinant interferon, on various syngeneic murine tumors.
    Iigo M, Sakurai M, Tamura T, Saijo N, Hoshi A.
    Cancer Res; 1988 Jan 15; 48(2):260-4. PubMed ID: 2446744
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antitumor effect of forphenicinol, a low molecular weight immunomodifier, on murine transplantable tumors and microbial infections.
    Ishizuka M, Masuda T, Kanbayashi N, Watanabe Y, Matsuzaki M, Sawazaki Y, Ohkura A, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1982 Aug 15; 35(8):1049-54. PubMed ID: 7142006
    [Abstract] [Full Text] [Related]

  • 12. Effect of forphenicinol, a low molecular weight immunomodifier, on the growth of and the immune responses to murine lymphoma EL4.
    Okura A, Naito K, Iizuka H, Ishizuka M, Takeuchi T, Umezawa H.
    J Biol Response Mod; 1987 Feb 15; 6(1):35-43. PubMed ID: 3559627
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Chemoimmunotherapy of L1210 leukemia with adriamycin, cyclophosphamide, and OK-432, and their effects on the generation of antitumor immunity.
    Ujiie T.
    Jpn J Cancer Res; 1987 Jul 15; 78(7):737-47. PubMed ID: 3114200
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of antitumor immunity in cyclophosphamide-induced rejection of subcutaneous nonpalpable MOPC-315 tumors.
    Mokyr MB, Hengst JC, Dray S.
    Cancer Res; 1982 Mar 15; 42(3):974-9. PubMed ID: 6977410
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparative effects of Corynebacterium parvum, Brucella abortus extract, Bacillus Calmette-Guérin, glucan, levamisole, and tilorone with or without cyclophosphamide on tumor growth, macrophage production, and macrophage cytotoxicity in a murine mammary tumor model.
    Fisher B, Gebhardt M.
    Cancer Treat Rep; 1978 Nov 15; 62(11):1919-30. PubMed ID: 728912
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 79.